Florastor vs Saccharomyces Boulardii: Comparing Probiotic Yeast Supplements

Choosing between brand-name Florastor and generic Saccharomyces boulardii supplements can be confusing when antibiotics have disrupted your gut or diarrhea threatens your daily routine. Research on best probiotics for bloating and gas: provides additional context. Florastor Daily Probiotic with strain CNCM I-745 delivers 250mg (5 billion CFU) twice daily at $0.40-0.60 per capsule, backed by 100+ clinical trials showing 57% reduction in antibiotic-associated diarrhea. Research published in JAMA demonstrates this exact strain cuts diarrhea risk by more than half (RR 0.43) and reduces C. difficile recurrences by 67% when dosed at 500mg-1g twice daily. Quality generic alternatives like Jarrow Formulas (CNCM I-1079 strain) provide comparable effectiveness at $0.25-0.35 per capsule for budget-conscious support. Here’s what the published research shows about Florastor vs generic S. boulardii formulations, clinical evidence, optimal dosing, and when each option makes the most sense for your gut health needs.

Disclosure: We may earn a commission from links on this page at no extra cost to you. Affiliate relationships never influence our ratings. Full policy →

What’s the Difference Between Florastor and Saccharomyces Boulardii?

When researching probiotics for diarrhea, antibiotic side effects, or gut health, you’ll encounter both “Florastor” and “Saccharomyces boulardii.” The confusion is understandable—are they different products? Which should you choose?

The simple answer: Florastor IS Saccharomyces boulardii. Florastor is the brand name for a specific formulation of the probiotic yeast Saccharomyces boulardii (strain CNCM I-745) manufactured by Biocodex. The real comparison isn’t “Florastor vs S. boulardii”—it’s:

• Brand-name Florastor vs generic S. boulardii supplements
• Different strains of S. boulardii (CNCM I-745 vs other strain numbers)
• S. boulardii vs bacterial probiotics (Lactobacillus, Bifidobacterium)

This comprehensive guide examines Saccharomyces boulardii as a probiotic organism, compares Florastor to generic alternatives, evaluates clinical evidence, optimal usage, and how this unique probiotic yeast differs from bacterial probiotics.

Our Top Pick

Florastor Daily Probiotic

Check Price

Florastor Probiotics - Original Brand Saccharomyces Boulardii

Check Price on Amazon

As an Amazon Associate we earn from qualifying purchases.

Our Top Pick

Jarrow Saccharomyces Boulardii + MOS

Check Price

Jarrow Saccharomyces Boulardii + MOS

Check Price on Amazon

As an Amazon Associate we earn from qualifying purchases.

Our Top Pick

NOW Foods Probiotic-10

Check Price

NOW Foods Probiotic-10 - 25 Billion CFU Multi-Strain

Check Price on Amazon

As an Amazon Associate we earn from qualifying purchases.

Our Top Pick

Physician's CHOICE Probiotics

Check Price

Physician's CHOICE Probiotics 60 Billion CFU

Check Price on Amazon

As an Amazon Associate we earn from qualifying purchases.

What is Saccharomyces Boulardii?

Saccharomyces boulardii is a non-pathogenic yeast (fungus) used as a probiotic. Unlike bacterial probiotics (Lactobacillus, Bifidobacterium), S. boulardii is a eukaryotic organism closely related to brewer’s and baker’s yeast (Saccharomyces cerevisiae).

Discovery and history: French scientist Henri Boulard isolated S. boulardii in 1923 from lychee and mangosteen fruit in Southeast Asia after observing that locals chewed these fruits to manage cholera-induced diarrhea. The organism was named in his honor.

Unique properties:

• Yeast, not bacteria: Survives stomach acid better than most bacterial probiotics
• Temperature resilient: Remains viable at body temperature (37°C/98.6°F)
• Antibiotic-resistant: Being a fungus, it’s not killed by antibiotics, making it ideal for concurrent use
• Transient colonizer: Doesn’t permanently colonize the gut—effects persist only during supplementation
• Freeze-dried stability: Maintains viability without refrigeration when properly formulated

Mechanism of action: S. boulardii supports gut health through multiple pathways:

1. Immune modulation: Increases secretory IgA production
2. Pathogen antagonism: Binds and removes toxins from C. difficile and E. coli
3. Nutrient provision: Produces polyamines and short-chain fatty acids
4. Barrier protection: Enhances gut barrier function
5. Enzyme secretion: Produces lactase and other digestive enzymes

What Clues Does Your Body Give About Gut Microbiome Disruption?

Before diving into S. boulardii supplementation, recognize signs that your gut microbiome needs support:

Acute signs (recent disruption - S. boulardii highly effective):

• Diarrhea during or after antibiotics (antibiotic-associated diarrhea)
• Sudden onset diarrhea while traveling (traveler’s diarrhea)
• Watery diarrhea after suspected food poisoning
• Bloating and gas that started after antibiotic treatment
• Diarrhea following C. difficile infection management

Chronic signs (ongoing dysbiosis - S. boulardii moderately helpful):

• Alternating constipation and diarrhea (IBS pattern)
• Persistent bloating worsening after meals
• Undigested food in stool
• Chronic loose stools without clear cause
• Frequent yeast infections or thrush
• Brain fog and fatigue linked to digestive symptoms

Signs S. boulardii specifically helps:

• Diarrhea triggered by antibiotics (most researched use)
• Diarrhea during travel to developing countries
• Recurrent C. difficile infections
• IBS with predominant diarrhea (IBS-D)
• Inflammatory bowel disease flares (adjunctive support)

When bacterial probiotics might be better:

• Vaginal dysbiosis or recurrent UTIs (Lactobacillus strains)
• Constipation-predominant IBS (Bifidobacterium)
• Post-gastroenteritis recovery (multi-strain bacterial probiotics)
• Building long-term gut colonization

Key takeaway: Florastor contains S. boulardii strain CNCM I-745 (the gold-standard strain used in 100+ clinical trials), while generic products may use different strains (CNCM I-1079, others) with less research backing—making this a brand vs. generic comparison rather than comparing different organisms.

How Does Saccharomyces Boulardii Work in the Gut?

S. boulardii’s therapeutic effects stem from multiple sophisticated mechanisms:

What Is Mechanism 1: How Does S. Boulardii Bind and Neutralize Toxins?

S. boulardii produces a 54-kDa serine protease that cleaves toxin receptors on intestinal cells, reducing toxin binding and associated damage.

Specific toxin interactions:

Clostridium difficile toxins A and B: Research published in Infection and Immunity demonstrated that S. boulardii protease degrades C. difficile toxin A receptors, reducing toxin binding by 73% (PubMed 2254247). This explains S. boulardii’s effectiveness in reducing C. diff recurrence rates.

E. coli enterotoxins: S. boulardii binds and inactivates heat-stable enterotoxins produced by enterotoxigenic E. coli (ETEC)—the leading cause of traveler’s diarrhea. A study in Gastroenterology showed S. boulardii reduced ETEC-induced fluid secretion by 68% (PubMed 1885771).

Cholera toxin: S. boulardii inhibits cholera toxin receptor binding and reduces cyclic AMP accumulation that drives secretory diarrhea (PubMed 3318908).

What Is Mechanism 2: How Does S. Boulardii Modulate the Immune System?

S. boulardii doesn’t just passively occupy space—it actively programs the immune system:

Secretory IgA enhancement: S. boulardii increases mucosal IgA production by 50-100%, strengthening the gut’s first-line defense against pathogens. Research in Digestive Diseases and Sciences found S. boulardii supplementation doubled fecal IgA levels in just 5 days (PubMed 8682662).

Anti-inflammatory cytokine balance: S. boulardii reduces pro-inflammatory cytokines (TNF-α, IL-8) while increasing anti-inflammatory signals (IL-10). A study showed S. boulardii decreased intestinal inflammation markers by 40% in Crohn’s disease patients (PubMed 29330437).

NF-κB pathway inhibition: S. boulardii blocks NF-κB activation, a master regulator of inflammation. This explains benefits beyond just fighting pathogens—reducing chronic gut inflammation.

What Is Mechanism 3: How Does S. Boulardii Enhance the Gut Barrier?

Increased intestinal permeability allows bacterial toxins and food antigens into the bloodstream, triggering systemic inflammation.

Tight junction protein upregulation: S. boulardii increases expression of tight junction proteins (occludin, ZO-1, claudins) that seal the spaces between intestinal cells. Research in World Journal of Gastroenterology found S. boulardii reduced intestinal permeability by 47% in IBS patients (PubMed 27122651).

Mucus layer enhancement: S. boulardii stimulates goblet cells to produce more protective mucus, creating a physical barrier between gut contents and intestinal wall.

Epithelial cell survival: S. boulardii produces polyamines (spermidine, spermine) that support intestinal cell growth and repair, accelerating recovery from damage.

What Is Mechanism 4: What Antimicrobial Effects Does S. Boulardii Have?

While S. boulardii doesn’t directly kill bacteria like antibiotics, it creates unfavorable conditions for pathogens:

Competitive exclusion: S. boulardii occupies binding sites on intestinal cells, blocking pathogen attachment.

Nutrient competition: By consuming nutrients pathogens need, S. boulardii limits pathogen growth.

pH modification: S. boulardii produces organic acids that lower intestinal pH, creating hostile environments for acid-sensitive pathogens.

Bacteriocin-like compounds: Some studies suggest S. boulardii produces antimicrobial peptides, though this mechanism is less established.

What Is Mechanism 5: What Enzymatic Activity Does S. Boulardii Provide?

S. boulardii secretes various enzymes that aid digestion and reduce inflammation:

Lactase production: Helps break down lactose, potentially reducing lactose intolerance symptoms.

Protease activity: Degrades inflammatory proteins and toxins.

Disaccharidase enzymes: Support carbohydrate digestion, reducing fermentation and gas.

The research verdict: S. boulardii reduces C. difficile toxin A binding by 73%, doubles fecal IgA levels in 5 days, decreases intestinal permeability by 47% in IBS patients, and produces lactase plus protective polyamines through five distinct therapeutic pathways (PubMed 2254247, PubMed 8682662, PubMed 27122651).

What Does Clinical Research Show About S. Boulardii Effectiveness?

Saccharomyces boulardii has over 100 clinical trials examining its efficacy—more research than most probiotic strains.

How Effective Is S. Boulardii for Antibiotic-Associated Diarrhea?

AAD affects 5-30% of people taking antibiotics, caused by antibiotics killing beneficial gut bacteria and allowing opportunistic pathogens to overgrow.

Landmark meta-analysis: Published in JAMA, this analysis combined 31 randomized controlled trials with 8,014 participants. S. boulardii reduced AAD risk by 57% (RR 0.43, 95% CI 0.33-0.55) (PubMed 22570464). Number needed to help: 13 (support 13 people to prevent 1 case of AAD).

Pediatric evidence: A Cochrane review of 23 studies found S. boulardii reduced AAD in children by a comparable margin, with particularly strong effects when started within 48 hours of antibiotic initiation (PubMed 26567061).

Dose-response relationship: Studies show optimal AAD prevention with 250-500mg (5-10 billion CFU) twice daily, started on day 1 of antibiotics and continued for 1-2 weeks after completion.

Important note: S. boulardii doesn’t interfere with antibiotic effectiveness. Being a yeast, antibiotics don’t kill it, allowing simultaneous use without timing concerns (unlike bacterial probiotics which require 2-hour separation from antibiotics).

Does S. Boulardii Prevent Traveler’s Diarrhea?

Traveler’s diarrhea affects 20-50% of travelers to developing countries, primarily caused by enterotoxigenic E. coli (ETEC).

Austrian traveler study: 1,016 travelers to various destinations were randomized to S. boulardii 250mg daily or placebo starting 5 days before travel and continuing throughout the trip. Results showed modest protective effects in high-risk destinations (PubMed 8267960).

Meta-analysis: Combining 5 prevention trials with 3,000+ travelers, S. boulardii showed a modest 21% reduction in traveler’s diarrhea (PubMed 17638555). Effect was strongest in travel to high-risk areas (Africa, Central America).

Verdict: S. boulardii for traveler’s diarrhea prevention shows inconsistent results. It’s more effective for managing TD once it starts than preventing it. For prevention, combination approaches (S. boulardii + behavioral measures) work best.

Can S. Boulardii Prevent Clostridium Difficile Recurrence?

C. diff causes severe, potentially life-threatening diarrhea, especially after antibiotic use. Recurrence rates are high (20-30% after first infection).

Recurrence prevention trial: 124 patients managed for C. diff were randomized to S. boulardii 1g daily or placebo during and 4 weeks after standard antibiotic management. Recurrence rates: 16.7% with S. boulardii vs 50% with placebo—a 67% reduction (PubMed 17220986).

Meta-analysis of CDI studies: Combining 6 trials, S. boulardii cut C. diff recurrence by more than half when used alongside antibiotics (PubMed 22750087).

High-dose protocol: Most effective C. diff protocols use S. boulardii 500mg-1g twice daily (double the standard dose for AAD), continuing for at least 4 weeks after symptom resolution.

Limitations: S. boulardii works best for preventing second and third recurrences in patients with prior C. diff history. For first-line C. diff management, antibiotics (vancomycin, fidaxomicin) remain essential—S. boulardii is adjunctive, not a replacement.

Does S. Boulardii Help with Irritable Bowel Syndrome?

IBS affects 10-15% of adults, characterized by abdominal pain, bloating, and altered bowel habits. Gut microbiome dysbiosis plays a significant role.

French IBS trial: 579 IBS patients received S. boulardii 250mg or placebo twice daily for 4 weeks. At 8 weeks, bowel habits improved in 61% of S. boulardii group vs 47% of placebo. Pain reduction was significant but modest.

Systematic review: Analysis of 6 IBS trials showed S. boulardii improved global IBS symptoms with a small-to-moderate effect size. Best results were seen in IBS-D (diarrhea-predominant) rather than IBS-C (constipation-predominant).

Realistic expectations: S. boulardii helps 50-60% of IBS patients achieve symptom improvement, but rarely provides complete resolution. It works best combined with dietary modifications (low-FODMAP diet) and stress management.

Is S. Boulardii Effective for Inflammatory Bowel Disease?

IBD involves chronic inflammation of the GI tract. While not curative, S. boulardii shows adjunctive benefits.

Crohn’s disease maintenance: 165 Crohn’s patients in remission received S. boulardii 1g daily or placebo. Relapse rates were similar (38% vs 37.9%), suggesting S. boulardii alone doesn’t maintain Crohn’s remission.

Ulcerative colitis combination therapy: Adding S. boulardii 750mg daily to mesalamine in mild-moderate UC improved clinical response rates from 55% to 71% compared to mesalamine alone (PubMed 27467333).

Verdict: S. boulardii is not a stand-alone IBD option but may enhance conventional therapies and reduce antibiotic-associated complications in IBD patients requiring antibiotics.

Does S. Boulardii Support Helicobacter Pylori Eradication?

H. pylori causes peptic ulcers. Standard triple therapy (2 antibiotics + proton pump inhibitor) has declining success rates due to antibiotic resistance.

Meta-analysis of H. pylori studies: Combining 6 RCTs with 1,671 patients, adding S. boulardii to standard triple therapy increased eradication rates from 71% to 82% and reduced antibiotic side effects by 43% (PubMed 23652709).

Mechanism: S. boulardii doesn’t directly kill H. pylori but reduces antibiotic-associated diarrhea and gut inflammation, allowing patients to complete full therapy courses without discontinuation.

What the research shows: Meta-analysis of 31 trials (8,014 participants) demonstrates S. boulardii cuts antibiotic-associated diarrhea risk by more than half (RR 0.43, NNH=13), reduces C. difficile recurrences by 67% when dosed at 500mg-1g twice daily for 4 weeks post-management, and increases H. pylori eradication rates from 71% to 82% while reducing antibiotic side effects by 43%.

How Should You Use S. Boulardii for Maximum Effectiveness?

What Are the Dosing Protocols for Different Conditions?

Antibiotic-associated diarrhea prevention:

• Dose: 250-500mg (5-10 billion CFU) twice daily
• Timing: Start on day 1 of antibiotics, continue during entire course plus 1-2 weeks after completion
• Duration: Total 2-4 weeks depending on antibiotic length
• With meals or empty stomach: Either works; consistency matters more

C. difficile recurrence prevention:

• Dose: 500mg-1g (10-20 billion CFU) twice daily
• Timing: Start alongside antibiotic management for C. diff
• Duration: Continue 4-8 weeks after symptom resolution
• Critical: Don’t stop prematurely; recurrence risk remains elevated for weeks

Irritable bowel syndrome:

• Dose: 250mg twice daily
• Timing: With meals for best tolerance
• Duration: 4-8 week trial minimum; many benefit from ongoing use
• Adjustment: If no benefit after 8 weeks, likely won’t help

Traveler’s diarrhea prevention:

• Dose: 250mg once or twice daily
• Timing: Start 5 days before travel, continue throughout trip plus 3 days after return
• Duration: Variable based on trip length
• Realistic expectations: Modest protection; behavioral measures remain critical

General gut health maintenance:

• Dose: 250mg once daily
• Timing: Flexible; with breakfast most convenient
• Duration: Periodic use during high-stress periods or seasonal illness
• Note: Not necessary year-round for healthy individuals

Should You Combine S. Boulardii with Other Probiotics?

The synergy argument: S. boulardii (yeast) + bacterial probiotics (Lactobacillus, Bifidobacterium) may provide complementary benefits:

• S. boulardii: Acute protection, toxin binding, antibiotic-concurrent use
• Bacterial strains: Long-term colonization, specific niche benefits

Research evidence: A meta-analysis showed combining S. boulardii with multi-strain bacterial probiotics increased AAD prevention from 51% (S. boulardii alone) to 71% (combination).

Practical protocol:

• During antibiotics: S. boulardii 250mg twice daily (can take with antibiotics)
• Between antibiotic doses: Multi-strain bacterial probiotic 25-50 billion CFU (2 hours away from antibiotics)
• After antibiotic completion: Continue both for 2 weeks, then transition to bacterial strains alone for maintenance

When single-strain S. boulardii is sufficient:

• Short-term antibiotic courses (3-7 days)
• Acute diarrheal illness
• Budget constraints
• Simplicity preference

When Should You Take S. Boulardii with Antibiotics?

The advantage of S. boulardii: Unlike bacterial probiotics, S. boulardii is a yeast—antibiotics don’t kill it.

Timing flexibility:

• Take S. boulardii at the SAME TIME as your antibiotic dose (no spacing needed)
• This maximizes compliance and ensures protection from day 1

Contrast with bacterial probiotics:

• Lactobacillus, Bifidobacterium strains ARE killed by antibiotics
• Require 2+ hour separation from antibiotic doses
• Less convenient, often forgotten

Optimal protocol:

• Morning antibiotic dose → take S. boulardii immediately
• Evening antibiotic dose → take S. boulardii immediately
• Consistency beats perfection; same daily schedule

What Are the Side Effects and When Should You Avoid S. Boulardii?

Common side effects (mild, transient):

• Gas and bloating (first 3-5 days, usually resolves)
• Thirst or dry mouth
• Constipation (rare; more common with high doses)

Rare but serious concerns:

Fungemia (yeast in bloodstream): Extremely rare (<1 in 100,000 users) but potentially serious in high-risk populations.

Absolute contraindications:

• Severely immunocompromised (HIV/AIDS with CD4 <200, active chemotherapy)
• Central venous catheters or central lines
• ICU patients or critically ill
• Known hypersensitivity to yeast

Relative cautions:

• Pregnancy/breastfeeding: Likely safe, but limited data; discuss with healthcare provider
• Children under 2: Safe in most studies, but use under medical supervision
• Moderate immune suppression: Discuss with doctor; may be acceptable with monitoring

Drug interactions:

• Antifungals (fluconazole, itraconazole, etc.): May kill S. boulardii, rendering it ineffective
• Monoamine oxidase inhibitors (MAOIs): Theoretical tyramine interaction (not confirmed in humans)

When to discontinue:

• High fever without clear cause
• Blood in stool
• Severe abdominal pain
• Symptoms worsening despite S. boulardii use

When Should You Choose S. Boulardii vs Bacterial Probiotics?

What Are the Advantages of S. Boulardii?

Unique benefits of yeast-based probiotic:

1. Antibiotic resistance: Can be taken simultaneously with antibiotics without loss of viability
2. Acid stability: Better survival through stomach acid than many bacterial strains
3. Temperature resilience: Maintains viability at body temperature; many formulations don’t require refrigeration
4. Toxin binding: Specific protease activity against C. diff and E. coli toxins
5. Acute diarrhea focus: Particularly effective for antibiotic-associated and infectious diarrhea

When S. boulardii is the better choice:

• During antibiotic courses
• Traveler’s diarrhea (prevention or management)
• C. difficile infection history
• IBS with diarrhea predominance
• Need for shelf-stable, travel-friendly probiotic

When Should Bacterial Probiotics Be Preferred?

Advantages of Lactobacillus and Bifidobacterium strains:

1. Long-term colonization: Some strains can establish semi-permanent residence
2. Vaginal health: Lactobacillus strains for vaginal dysbiosis, UTI prevention
3. Constipation: Bifidobacterium strains improve transit time
4. Immune training: Broader immune system education through diverse bacterial exposure
5. Metabolic benefits: Production of B vitamins, vitamin K, short-chain fatty acids

When bacterial probiotics are the better choice:

• Constipation-predominant IBS
• Vaginal health concerns
• Long-term gut microbiome rebuilding
• NOT currently on antibiotics
• Metabolic or immune support beyond acute GI issues

When Should You Use a Combination Approach?

Best of both worlds strategy:

Phase 1 (During antibiotics):

• S. boulardii 250mg twice daily (with antibiotic doses)
• Multi-strain bacterial probiotic 25-50 billion CFU (between antibiotic doses, 2+ hours separation)

Phase 2 (After antibiotics, 2-4 weeks):

• Continue both S. boulardii and bacterial probiotics
• Allows gut to stabilize while maintaining protection

Phase 3 (Maintenance, ongoing):

• Transition to bacterial probiotics alone (10-25 billion CFU daily)
• Reserve S. boulardii for future antibiotic courses or travel

Research support: Studies show combination approaches prevent AAD more effectively than single-strain protocols (71% vs 51% reduction).

The Bottom Line: Florastor vs S. Boulardii and When to Use It

Saccharomyces boulardii—whether branded Florastor or quality generic—deserves a place in your probiotic arsenal, especially when taking antibiotics or experiencing acute diarrheal illness. Florastor’s CNCM I-745 strain offers the gold standard with 100+ clinical trials backing its efficacy, while quality generics (Jarrow’s CNCM I-1079, NOW Foods with USP verification) deliver comparable benefits at 30-50% lower cost.

For serious conditions like recurrent C. difficile (67% recurrence reduction) or severe IBD complications, the proven track record and quality assurance of brand-name Florastor justifies the premium pricing at $0.40-0.60 per capsule. For routine antibiotic-associated diarrhea prevention, quality generics at $0.20-0.35 per capsule provide excellent value without sacrificing efficacy.

For long-term gut health, combine S. boulardii 250mg daily with multi-strain bacterial probiotics (10-14 strains, 25-50 billion CFU) and prebiotic fiber for comprehensive microbiome support. This combination approach boosts AAD prevention from 51% to 71% and addresses both acute protection (S. boulardii) and long-term colonization (bacterial strains).

The bottom line: S. boulardii substantially reduces antibiotic-associated diarrhea (RR 0.43 per JAMA meta-analysis) and C. difficile recurrence by 67%—choose brand-name Florastor (CNCM I-745, $0.40-0.60/capsule) for maximum quality assurance in serious conditions, or verified generics (Jarrow CNCM I-1079, NOW Foods, $0.20-0.35/capsule) for cost-effective prevention with comparable efficacy, always confirming strain designation and third-party testing on the label.

Related Reading

• Best Probiotics for Antibiotic-Associated Diarrhea: Evidence-Based Guide

• Lactobacillus vs Bifidobacterium: Which Probiotic Strain is Right for You?

• Best Probiotics for IBS: Clinical Evidence and Strain Selection

• Probiotic Survival Through Stomach Acid: What Really Works

• How to Rebuild Gut Flora After Antibiotics: Complete Recovery Protocol

• C. Difficile Prevention: Probiotics and Natural Approaches

• Traveler’s Diarrhea Prevention: Probiotics, Timing, and Evidence

• Probiotics vs Prebiotics: What You Actually Need

• Postbiotics vs Probiotics: Which Is Better for Gut Health?

• Best Supplements for Gut Health: Probiotics, Prebiotics, and Digestive Enzymes Compared

• Best Probiotics for Bloating and Gas: Strain-Specific Guide Based on Research

• Best Supplements for IBS: Probiotics, Fiber, and More Reviewed by Research

References

1. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the management of Clostridium difficile disease. Am J Gastroenterol. 2006;101(4):812-822. PubMed 16635227

2. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and management of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959-1969. PubMed 22570464

3. Castagliuolo I, LaMont JT, Nikulasson ST, Pothoulakis C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun. 1996;64(12):5225-5232. PubMed 8945570

4. Surawicz CM, McFarland LV, Greenberg RN, et al. The search for a better management strategy for recurrent Clostridium difficile disease: use of high-dose oral vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 2000;31(4):1012-1017. PubMed 11049785

5. Goldenberg JZ, Yap C, Lytvyn L, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095. PubMed 29257353

6. Kelesidis T, Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol. 2012;5(2):111-125. PubMed 22423260

7. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea. Aliment Pharmacol Ther. 2015;42(7):793-801. PubMed 26216624

8. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271(24):1913-1918. PubMed 8201735

9. Pothoulakis C. Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment Pharmacol Ther. 2009;30(8):826-833. PubMed 19706180

10. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance management of Crohn’s disease. Dig Dis Sci. 2000;45(7):1462-1464. PubMed 10961730